First Wilshire Securities Management’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-56,244
Closed -$3.03M 86
2023
Q2
$3.03M Sell
56,244
-150,084
-73% -$6.65M 1.04% 28
2023
Q1
$8.2M Sell
206,328
-155,119
-43% -$6.54M 2.8% 12
2022
Q4
$14.5M Sell
361,447
-5,879
-2% -$221K 5.09% 5
2022
Q3
$11.8M Sell
367,326
-428
-0.1% -$14.7K 4.78% 6
2022
Q2
$10.9M Buy
367,754
+39,825
+12% +$1.15M 4.07% 7
2022
Q1
$9.22M Sell
327,929
-565
-0.2% -$21.1K 3.24% 8
2021
Q4
$15.1M Sell
328,494
-5,192
-2% -$223K 4.72% 6
2021
Q3
$11M Buy
333,686
+94,585
+40% +$2.94M 3.63% 8
2021
Q2
$8.38M Buy
239,101
+19,139
+9% +$651K 2.93% 9
2021
Q1
$7.95M Buy
219,962
+59,166
+37% +$1.85M 2.97% 8
2020
Q4
$4.67M Buy
+160,796
New +$4.6M 1.88% 17

Other funds holding ANIP